NCT01464450View on ClinicalTrials.gov

Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
PharmacokineticsBioavailabilityHealthy Participants
Interventions
DRUG

Rivaroxaban

Single 20 mg-dose

Trial Locations (1)

Unknown

Neptune City

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Janssen Scientific Affairs, LLC

INDUSTRY

NCT01464450 - Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants | Biotech Hunter | Biotech Hunter